Skip to main content

Antibiotic Recalled

July 20, 2018

Lupin Somerset is voluntarily pulling 2 lots of nitrofurantoin oral suspension, USP, 25 mg/5 mL (NDC 43386-450-11), because the drug is subpotent, according to the July 18, 2018, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 230-mL bottles manufactured for Lupin Pharmaceuticals by Novel Laboratories from lots S700065 (Exp. 2/19) and 700619 (Exp. 8/19). Bottles from the lots were distributed within the United States.

Lupin initiated the recall June 28, 2018. At press time, the FDA had not yet issued a recall classification.

Nitrofurantoin oral suspension is a prescription antibiotic used to treat or prevent urinary tract infections.

Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here

Back to Top